The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

A randomized treatment trial studying the effectiveness of endovascular stroke therapy in large vessel occlusion stroke patients with moderate to large infarcts at baseline.

The primary objective of the trial is to establish the effectiveness of IAT (versus medical management) in patients with moderate-large infarcts (NCCT ASPECTS 2-5) at baseline, with adaptive enrichment to better define the upper limit of infarct volume for treatment eligibility. Furthermore, the investigators aim to determine whether certain subgroups of patients with large baseline infarcts will have a greater treatment benefit. Finally, the investigators will assess the agreement of ASPECTS scores between site investigators, the core imaging lab, and automated software.

Check your eligibility (clinicaltrials.gov)
Participate in a Clinical Trial at Saint John’s Cancer Research Institute

Questions regarding this trial: 310-303-5515